The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AADI BIOSCIENCES INC COM 00032Q104 18,842 1,529,402 SH   SOLE   1,529,402 0 0
AC IMMUNE SA COM 99P1VHX22 354 100,000 SH Call SOLE   100,000 0 0
ACADIA PHARMACEUTICALS INC COM 004225108 1,007 71,500 SH   SOLE   71,500 0 0
ACLARIS THERAPEU COM 00461U105 2,692 192,835 SH   SOLE   192,835 0 0
APELLIS PHARMACEUTICALS INC COM 03753U106 25,052 554,000 SH   SOLE   554,000 0 0
ARCUS BIOSCIENCES INC COM 03969F109 4,244 167,500 SH   SOLE   167,500 0 0
ARROWHEAD PHARMACEUTICALS INC COM 04280A100 2,180 61,926 SH   SOLE   61,926 0 0
ATHIRA PHARMA INC COM 99P19TV23 340 100,000 SH Call SOLE   100,000 0 0
BCLS ACQUISITION CORP- CL A COM CL A G0904B105 8,347 843,122 SH   SOLE   843,122 0 0
BELLUS HEALTH INC COM NEW 07987C204 7,540 816,000 SH   SOLE   816,000 0 0
CELLDEX THERAPEUTICS INC COM NEW 15117B202 7,204 267,195 SH   SOLE   267,195 0 0
ENANTA PHARMACEUTICALS INC COM 29251M106 1,300 27,500 SH   SOLE   27,500 0 0
EYEPOINT PHARMACEUTICALS INC COM NEW 30233G209 2,388 303,396 SH   SOLE   303,396 0 0
FULCRUM THERAPEUTICS INC COM 359616109 980 200,000 SH   SOLE   200,000 0 0
GH RESEARCH PLC ORDINARY SHARES G3855L106 2,428 243,250 SH   SOLE   243,250 0 0
GOSSAMER BIO INC COM 38341P102 268 32,000 SH   SOLE   32,000 0 0
HEALTH SCIENCES ACQUISITIONS ORD SHS G4411D109 3,909 392,500 SH   SOLE   392,500 0 0
HORIZON THERAPEUTICS PLC SHS G46188101 2,862 35,888 SH   SOLE   35,888 0 0
IOVANCE BIOTHERAPEUTICS INC COM 462260100 1,704 154,356 SH   SOLE   154,356 0 0
ITEOS THERAPEUTICS INC COM 46565G104 1,277 62,000 SH   SOLE   62,000 0 0
IVERIC BIO INC COM 46583P102 5,422 563,607 SH   SOLE   563,607 0 0
JIYA ACQUISITION CORP -CL A COM CL A 47760M102 5,552 562,500 SH   SOLE   562,500 0 0
KURA ONCOLOGY INC. COMMON STOCK COM 50127T109 9,834 536,500 SH   SOLE   536,500 0 0
MERUS BV COM N5749R100 3,487 154,000 SH   SOLE   154,000 0 0
MILESTONE PHARMACEUTICALS IN COM 59935V107 2,812 457,200 SH   SOLE   457,200 0 0
MIRATI THERAPEUTICS COM 60468T105 6,344 94,500 SH   SOLE   94,500 0 0
NUVATION BIO INC *W EXP 07/07/202 67080N119 25 90,832 SH   SOLE   90,832 0 0
OCULAR THERAPEUTIX INC COM 67576A100 53 13,171 SH   SOLE   13,171 0 0
PMV PHARMACEUTICALS INC COM 69353Y103 2,173 152,500 SH   SOLE   152,500 0 0
PRECISION BIOSCIENCES INC COM 74019P108 3,281 2,050,359 SH   SOLE   2,050,359 0 0
PYXIS ONCOLOGY INC COMMON STOCK 747324101 1,535 645,149 SH   SOLE   645,149 0 0
RELMADA THERAPEUTICS INC COM 75955J402 6,694 352,500 SH   SOLE   352,500 0 0
REZOLUTE INC COM NEW 76200L309 2,084 645,136 SH   SOLE   645,136 0 0
ROCHE GS COM 993960LE1 5,338 16,000 SH   SOLE   16,000 0 0
SPRINGWORKS THERAPEUTICS INC COM 85205L107 123 5,000 SH   SOLE   5,000 0 0
SYNDAX PHARMACEUTICALS INC COM 87164F105 3,944 205,003 SH   SOLE   205,003 0 0
TREVI THERAPEUTICS INC COM 89532M101 98 35,000 SH   SOLE   35,000 0 0
UNITED THERAPEUTICS CORP DEL COM 91307C102 3,063 13,000 SH   SOLE   13,000 0 0
VENTYX BIOSCIENCES INC COM 92332V107 1,492 122,000 SH   SOLE   122,000 0 0
VERASTEM INC COM 92337C104 232 200,000 SH   SOLE   200,000 0 0
VIRIDIAN THERAPEUTICS INC COM 92790C104 2,708 234,026 SH   SOLE   234,026 0 0
VISTAGEN THERAPEUTICS INC COM NEW 92840H202 9,998 11,361,451 SH   SOLE   11,361,451 0 0
XENON PHARMACEUTICALS INC COM 98420N105 8,289 272,500 SH   SOLE   272,500 0 0